Industry News, Trustworthy Insights

Popular Companies:

Evercore, Citi: Advisory on Eli Lilly’s $3.2bn Acquisition of Morphic

Evercore, alongside Citi, has been enlisted as the financial advisor for Eli Lilly in its strategic acquisition of Morphic Holding, Inc., a deal poised to reshape treatment options for inflammatory bowel disease (IBD).

Evercore. PHOTO: File Photo
Evercore. PHOTO: File Photo

Valued at approximately $3.2 billion, this acquisition will see Lilly purchasing all outstanding shares of Morphic for $57 each, a significant premium over recent trading prices.

This move is approved by

Industry news used by professionals

Try £4.99 per month

Already a member?
Weekly Digest

All the week’s industry events straight to your inbox.

Before your sign up, please read terms of use and privacy policy.

Trending

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to our terms of use and privacy policy.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Password Reset

You will soon receive a Reset Password link

FREE Weekly Newsletter

Trusted industry insights used by Professionals

By signing up you agree to terms of use and privacy policy.

Send us your article

popup

Maximum file size: 2.1MB

Start Over